Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.
2.

CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer.

Kleer CG, Zhang Y, Merajver SD.

Cells Tissues Organs. 2007;185(1-3):95-9. Review.

PMID:
17587813
3.

CCN6: a modulator of breast cancer progression.

Leask A.

J Cell Commun Signal. 2016 Jun;10(2):163-4. doi: 10.1007/s12079-016-0321-2. Epub 2016 Apr 16. Review.

4.

Biological characteristics of CCN proteins in tumor development.

Barreto SC, Ray A, Ag Edgar P.

J BUON. 2016 Nov-Dec;21(6):1359-1367. Review.

PMID:
28039692
5.

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?

Zielinska HA, Bahl A, Holly JM, Perks CM.

Breast Cancer (Dove Med Press). 2015 Jan 19;7:9-19. doi: 10.2147/BCTT.S43932. eCollection 2015. Review.

6.

Non-collagenic etiologies of muscle weakness with joint deformities: about two paradigmatic case reports.

Urtizberea JA, Thambyayah M, Nishino I, Megarbane A.

Acta Myol. 2005 Oct;24(2):78-9. Review.

PMID:
16550920

Supplemental Content

Support Center